You are here

Article info

Article menu

Download PDFPDF

Review
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

Authors

  1. ↵a jpd4401{at}aol.com
  2. ↵b dschwart{at}iuhealth.org
  3. ↵c howard.kaufman{at}rutgers.edu
  4. ↵d agarwas{at}slhn.org
  5. ↵e tarhiniaa{at}upmc.edu
  6. ↵f jlowder{at}prometheuslabs.com
  7. ↵g mba41{at}georgetown.edu
View Full Text

Citation

Dutcher JP, Schwartzentruber DJ, Kaufman HL, et al
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
Journal for ImmunoTherapy of Cancer 2014;2:26. doi: 10.1186/s40425-014-0026-0

Publication history

  • Received April 25, 2014
  • Accepted July 16, 2014
  • First published September 16, 2014.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.